Cooperative Agreement U65PS004941

This $1,272,341 cooperative agreement from the Centers for Disease Control and Prevention will support efforts to promote pre-exposure prophylaxis (PrEP) adherence among men who have sex with men of color. Awarded under the HIV Demonstration, Research, Public and Professional Education Projects program (CFDA 93.941), the University of North Carolina at Chapel Hill will work to develop and test improved HIV prevention strategies from September 2021 through October 2022. A subaward of $250,000...

The U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA) awarded a $300,000 Project Grant under the Ryan White HIV/AIDS Program HIV-Related Training and Technical Assistance Federal Grant Program (CFDA 93.145) to the Jwch Institute, Inc., a non-profit Federally Qualified Health Center in Commerce, CA. The grant, which runs from September 1, 2024 to August 31, 2025, will support comprehensive educational and capacity-building initiatives designed to...

Federal Cooperative Agreement Summary The Philadelphia Department of Public Health Division of HIV Health received a $579,853 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) National Center for HIV/AIDS under the HIV Prevention and Surveillance Activities-Health Department Based program (CFDA 93.940), effective September 30, 2025, through September 29, 2030. This five-year award supports comprehensive HIV and tuberculosis prevention efforts, including targeted...

Federal Project Grant Award Summary Partnership For Research And Action For Health received a $192,292 Project Grant from the National Institutes of Health Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989), effective April 1, 2026 through March 31, 2029. The grant funds an intervention adaptation and pilot randomized controlled trial addressing HIV prevention and stigma reduction among men who have sex with men (MSM) in the Georgian...

Project Renewal, Inc. received $117,968.13 under the HIV-Related Training and Technical Assistance program (CFDA 93.145) administered by the Health Resources and Services Administration (HRSA) HIV/AIDS Bureau, with an award date of September 1, 2025, and completion date of August 31, 2026. The funding supports infrastructure development and emergency preparedness capacity building for PRI's HIV program, which serves approximately 50 individuals living with HIV/AIDS at any given time in New...

Project Summary: MISTR+ Study on Telehealth PrEP Delivery The National Institute of Allergy and Infectious Diseases (NIAID) awarded Emory University $1,273,269 on June 2, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct the MISTR+ study, which will operate through May 31, 2031. This project aims to establish an evidence base for telemedicine-delivered HIV pre-exposure prophylaxis (PrEP) and improve health outcomes for over 100,000 users of the largest...

Cicatelli Associates, Inc. (CAI) received a $1.5 million Project Grant from the Health Resources and Services Administration (HRSA) under the HIV Emergency Relief Project Grants program (CFDA 93.914), effective April 1, 2026 through March 31, 2027. The award funds national training and technical assistance to strengthen the capacity of Ryan White HIV/AIDS Program (RWHAP) Parts A, B, C, D, and F to use collaborative and coordinated approaches in identifying and engaging people with HIV who are...

Federal Project Grant Award Summary The University of Miami Miller School of Medicine's Ryan White Part C Program received $449,997 in supplemental funding from the Health Resources and Services Administration's HIV/AIDS Bureau under the HIV-Related Training and Technical Assistance program (CFDA 93.145) for the period September 1, 2025, through August 31, 2026. The award supports the development and implementation of the CUES Intervention (Confidentiality, Universal Education, Empowerment,...

This Project Grant award in the amount of $431,712, funded by the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to improve HIV testing among children under five in rural Uganda. The primary goal is to engage with traditional healers to facilitate HIV counseling and testing via oral swab antigen tests for this vulnerable pediatric population. The award supports two key activities: 1) determining barriers and...

Medical Monitoring Project – Houston Health Department The Centers for Disease Control and Prevention (CDC), through its National Center for HIV/AIDS, awarded the Houston Department of Health and Human Services a Cooperative Agreement totaling $1,463,690 under the HIV Prevention and Surveillance Activities-Health Department Based program (CFDA 93.940). The award, effective September 30, 2025, with a completion date of September 29, 2030, funds the implementation of the Medical Monitoring Project...